Retatrutide (10 mg Vial)
Handling notes for Retatrutide (10 mg Vial), supplied lyophilized. Covers the reconstitution volume and concentration it yields, U-100 syringe unit equivalents, per-protocol consumable counts and storage conditions.
CAT No:
CAS No:
Synonyms/Alias:Retatrutide
M.F/Formula:
M.W/Mr.:
Purity:Specification by inquiry
- Sequence, purity and scale confirmation
- CoA and technical documentation requests
- API, research and cosmetic peptide options
- Distributor and institution quotation support
Handling notes for Retatrutide (10 mg Vial), supplied lyophilized. Covers the reconstitution volume and concentration it yields, U-100 syringe unit equivalents, per-protocol consumable counts and storage conditions.
Quickstart
Reconstitute: Add 1.0 mL bacteriostatic water → ~ 10.0 mg/mL concentration.
Typical weekly range: 2–8 mg once weekly (gradual escalation over 8–12 weeks).
Easy measuring: At 10.0 mg/mL, 1 unit = 0.01 mL ≈ 100 mcg on a U-100 insulin syringe.
Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) for up to 4 weeks.
Notes
Practical considerations for consistency and safety. Use new sterile insulin syringes for each injection; dispose in a sharps container [14]. Rotate injection sites (abdomen, thighs, upper arms) systematically to reduce local irritation and lipohypertrophy [13]. For doses >10 mg with 1.0 mL reconstitution, prepare multiple vials to obtain the required volume. For volumes >1.0 mL, split into 2 separate injections at different sites for better absorption [5]. Inject slowly; wait a few seconds before withdrawing the needle to ensure full dose delivery. Document weekly dose, date, and injection
Single peptide protocol reference : Available for related research, development or formulation inquiry workflows.: Available for related research, development or formulation inquiry workflows.
Reconstitution and handling reference : Available for related research, development or formulation inquiry workflows.: Available for related research, development or formulation inquiry workflows.
Research-use documentation inquiry : Available for related research, development or formulation inquiry workflows.: Available for related research, development or formulation inquiry workflows.
Peptide Vials (Retatrutide, 10 mg each): 12 weeks (Standard to 6 mg): 5 vials
24 weeks (Standard to 8 mg): 15 vials
12 weeks (Aggressive to 8 mg): 6 vials
Insulin Syringes (U-100, 1 mL capacity): Per week: 1–2 syringes (depending on dose; higher doses require split injections)
12 weeks: 12–24 syringes
24 weeks: 24–48 syringes
Bacteriostatic Water (10 mL bottles): Use ~1.0 mL per vial for reconstitution. 12 weeks (5 vials): 5 mL → 1 × 10 mL bottle
24 weeks (15 vials): 15 mL → 2 × 10 mL bottles
Alcohol Swabs: One for the vial stopper + one for each injection site. Per week: 2–4 swabs (1 per vial + 1–2 per injection site)
12 weeks: ~50 swabs → recommend 1 × 100-count box
24 weeks: ~100 swabs → recommend 1 × 100-count box
Send product, purity, quantity, destination and documentation requirements. Our team will follow up through online consultation or email.
WhatsApp: +852 52102460 +1 4422847013
Address: Huangpu District, Guangzhou, China